0RAR Stock Overview
Designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Stratec SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €28.95 |
| 52 Week High | €48.55 |
| 52 Week Low | €26.35 |
| Beta | 0.26 |
| 1 Month Change | 3.95% |
| 3 Month Change | -32.76% |
| 1 Year Change | -32.28% |
| 3 Year Change | -78.60% |
| 5 Year Change | -54.16% |
| Change since IPO | -40.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0RAR | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -9.8% | -2.3% | -2.2% |
| 1Y | -32.3% | -10.6% | 2.4% |
Return vs Industry: 0RAR underperformed the UK Medical Equipment industry which returned -10.6% over the past year.
Return vs Market: 0RAR underperformed the UK Market which returned 2.4% over the past year.
Price Volatility
| 0RAR volatility | |
|---|---|
| 0RAR Average Weekly Movement | 8.1% |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0RAR's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: 0RAR's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 1,462 | Marcus Wolfinger | www.stratec.com |
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Stratec SE Fundamentals Summary
| 0RAR fundamental statistics | |
|---|---|
| Market cap | €352.52m |
| Earnings (TTM) | €10.01m |
| Revenue (TTM) | €250.54m |
35.2x
P/E Ratio1.4x
P/S RatioIs 0RAR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0RAR income statement (TTM) | |
|---|---|
| Revenue | €250.54m |
| Cost of Revenue | €182.78m |
| Gross Profit | €67.75m |
| Other Expenses | €57.74m |
| Earnings | €10.01m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 27, 2025
| Earnings per share (EPS) | 0.82 |
| Gross Margin | 27.04% |
| Net Profit Margin | 4.00% |
| Debt/Equity Ratio | 67.0% |
How did 0RAR perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield67%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 04:55 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Stratec SE is covered by 20 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Volker Braun | Bankhaus Lampe KG |
| Odysseas Manesiotis | Berenberg |
| Scott Bardo | Berenberg |